BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mehla K, Singh PK. MUC1: a novel metabolic master regulator. Biochim Biophys Acta 2014;1845:126-35. [PMID: 24418575 DOI: 10.1016/j.bbcan.2014.01.001] [Cited by in Crossref: 20] [Cited by in F6Publishing: 44] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Gebregiworgis T, Purohit V, Shukla SK, Tadros S, Chaika NV, Abrego J, Mulder SE, Gunda V, Singh PK, Powers R. Glucose Limitation Alters Glutamine Metabolism in MUC1-Overexpressing Pancreatic Cancer Cells. J Proteome Res 2017;16:3536-46. [PMID: 28809118 DOI: 10.1021/acs.jproteome.7b00246] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 3.2] [Reference Citation Analysis]
2 Deng X, Jiang P, Chen J, Li J, Li D, He Y, Jiang Y, Zhang Y, Xu S, Li X, Wang S, Tian F. GATA6 promotes epithelial-mesenchymal transition and metastasis through MUC1/β-catenin pathway in cholangiocarcinoma. Cell Death Dis 2020;11:860. [PMID: 33060563 DOI: 10.1038/s41419-020-03070-z] [Reference Citation Analysis]
3 King RJ, Yu F, Singh PK. Genomic alterations in mucins across cancers. Oncotarget 2017;8:67152-68. [PMID: 28978023 DOI: 10.18632/oncotarget.17934] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
4 Qin C, Yang G, Yang J, Ren B, Wang H, Chen G, Zhao F, You L, Wang W, Zhao Y. Metabolism of pancreatic cancer: paving the way to better anticancer strategies. Mol Cancer 2020;19:50. [PMID: 32122374 DOI: 10.1186/s12943-020-01169-7] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 14.5] [Reference Citation Analysis]
5 Tadros S, Shukla SK, King RJ, Gunda V, Vernucci E, Abrego J, Chaika NV, Yu F, Lazenby AJ, Berim L, Grem J, Sasson AR, Singh PK. De Novo Lipid Synthesis Facilitates Gemcitabine Resistance through Endoplasmic Reticulum Stress in Pancreatic Cancer. Cancer Res. 2017;77:5503-5517. [PMID: 28811332 DOI: 10.1158/0008-5472.can-16-3062] [Cited by in Crossref: 60] [Cited by in F6Publishing: 49] [Article Influence: 12.0] [Reference Citation Analysis]
6 Gunda V, Kumar S, Dasgupta A, Singh PK. Hypoxia-Induced Metabolomic Alterations in Pancreatic Cancer Cells. Methods Mol Biol 2018;1742:95-105. [PMID: 29330793 DOI: 10.1007/978-1-4939-7665-2_9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
7 Shukla SK, Purohit V, Mehla K, Gunda V, Chaika NV, Vernucci E, King RJ, Abrego J, Goode GD, Dasgupta A, Illies AL, Gebregiworgis T, Dai B, Augustine JJ, Murthy D, Attri KS, Mashadova O, Grandgenett PM, Powers R, Ly QP, Lazenby AJ, Grem JL, Yu F, Matés JM, Asara JM, Kim JW, Hankins JH, Weekes C, Hollingsworth MA, Serkova NJ, Sasson AR, Fleming JB, Oliveto JM, Lyssiotis CA, Cantley LC, Berim L, Singh PK. MUC1 and HIF-1alpha Signaling Crosstalk Induces Anabolic Glucose Metabolism to Impart Gemcitabine Resistance to Pancreatic Cancer. Cancer Cell 2017;32:71-87.e7. [PMID: 28697344 DOI: 10.1016/j.ccell.2017.06.004] [Cited by in Crossref: 163] [Cited by in F6Publishing: 172] [Article Influence: 32.6] [Reference Citation Analysis]
8 Nawaz MA, Rauf S, Catanante G, Nawaz MH, Nunes G, Marty JL, Hayat A. One Step Assembly of Thin Films of Carbon Nanotubes on Screen Printed Interface for Electrochemical Aptasensing of Breast Cancer Biomarker. Sensors (Basel) 2016;16:E1651. [PMID: 27782067 DOI: 10.3390/s16101651] [Cited by in Crossref: 33] [Cited by in F6Publishing: 17] [Article Influence: 5.5] [Reference Citation Analysis]
9 Patel JD, Lee JW, Carbone DP, Wagner H, Shanker A, de Aquino MTP, Horn L, Johnson ML, Gerber DE, Liu JJ, Das MS, Al-Nsour MA, Dakhil CSR, Ramalingam S, Schiller JH. Phase II Study of Immunotherapy With Tecemotide and Bevacizumab After Chemoradiation in Patients With Unresectable Stage III Non-Squamous Non-Small-Cell Lung Cancer (NS-NSCLC): A Trial of the ECOG-ACRIN Cancer Research Group (E6508). Clin Lung Cancer 2020;21:520-6. [PMID: 32807654 DOI: 10.1016/j.cllc.2020.06.007] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Shukla SK, Gunda V, Abrego J, Haridas D, Mishra A, Souchek J, Chaika NV, Yu F, Sasson AR, Lazenby AJ. MUC16-mediated activation of mTOR and c-Myc reprograms pancreatic cancer metabolism. Oncotarget. 2015;6:19118-19131. [PMID: 26046375 DOI: 10.18632/oncotarget.4078] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 6.3] [Reference Citation Analysis]
11 Olou AA, King RJ, Yu F, Singh PK. MUC1 oncoprotein mitigates ER stress via CDA-mediated reprogramming of pyrimidine metabolism. Oncogene 2020;39:3381-95. [PMID: 32103170 DOI: 10.1038/s41388-020-1225-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
12 Wi D, Cha J, Jung Y. Mucin in cancer: a stealth cloak for cancer cells. BMB Rep 2021;54:344-55. [DOI: 10.5483/bmbrep.2021.54.7.064] [Reference Citation Analysis]
13 Periasamy S, Lin CH, Nagarajan B, Sankaranarayanan NV, Desai UR, Liu MY. Mucoadhesive role of tamarind xyloglucan on inflammation attenuates ulcerative colitis. J Funct Foods 2018;47:1-10. [PMID: 30555535 DOI: 10.1016/j.jff.2018.05.035] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 4.5] [Reference Citation Analysis]
14 Shukla SK, Mulder SE, Singh PK. Hypoxia-Mediated In Vivo Tumor Glucose Uptake Measurement and Analysis. Methods Mol Biol 2018;1742:107-13. [PMID: 29330794 DOI: 10.1007/978-1-4939-7665-2_10] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
15 Kurashige T, Takahashi T, Nagano Y, Sugie K, Maruyama H. Krebs von den Lungen 6 decreased in the serum and muscle of GNE myopathy patients. Neuropathology 2021;41:29-36. [PMID: 33225515 DOI: 10.1111/neup.12703] [Reference Citation Analysis]
16 Trimarchi H, Paulero M, Rengel T, González-Hoyos I, Forrester M, Lombi F, Pomeranz V, Iriarte R, Iotti A. Mucin-1 Gene Mutation and the Kidney: The Link between Autosomal Dominant Tubulointerstitial Kidney Disease and Focal and Segmental Glomerulosclerosis. Case Rep Nephrol 2018;2018:9514917. [PMID: 30155326 DOI: 10.1155/2018/9514917] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
17 Yu Z, Huang S, Li Y, Niu Y, Chen H, Wu J. Milk Fat Globule Membrane Alleviates Short Bowel Syndrome-Associated Liver Injury in Rats Through Inhibiting Autophagy and NLRP3 Inflammasome Activation. Front Nutr 2022;9:758762. [DOI: 10.3389/fnut.2022.758762] [Reference Citation Analysis]
18 Kato K, Lillehoj EP, Lu W, Kim KC. MUC1: The First Respiratory Mucin with an Anti-Inflammatory Function. J Clin Med 2017;6:E110. [PMID: 29186029 DOI: 10.3390/jcm6120110] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
19 Shukla SK, King RJ, Singh PK. Transcriptional Profiling Using RNA-Seq to Study Hypoxia-Mediated Gene Regulation. Methods Mol Biol 2018;1742:55-66. [PMID: 29330790 DOI: 10.1007/978-1-4939-7665-2_6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
20 Goodwin PJ, Dowling RJO, Ennis M, Chen BE, Parulekar WR, Shepherd LE, Gelmon KA, Whelan TJ, Ligibel JA, Hershman DL, Mayer IA, Hobday TJ, Rastogi P, Rabaglio-Poretti M, Lemieux J, Thompson AM, Rea DW, Stambolic V. Cancer Antigen 15-3/Mucin 1 Levels in CCTG MA.32: A Breast Cancer Randomized Trial of Metformin vs Placebo. JNCI Cancer Spectr 2021;5:pkab066. [PMID: 34485814 DOI: 10.1093/jncics/pkab066] [Reference Citation Analysis]
21 Murthy D, Attri KS, Singh PK. Phosphoinositide 3-Kinase Signaling Pathway in Pancreatic Ductal Adenocarcinoma Progression, Pathogenesis, and Therapeutics. Front Physiol 2018;9:335. [PMID: 29670543 DOI: 10.3389/fphys.2018.00335] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 8.8] [Reference Citation Analysis]
22 Hanson RL, Brown RB, Steele MM, Grandgenett PM, Grunkemeyer JA, Hollingsworth MA. Identification of FRA-1 as a novel player in pancreatic cancer in cooperation with a MUC1: ERK signaling axis. Oncotarget 2016;7:39996-40011. [PMID: 27220889 DOI: 10.18632/oncotarget.9557] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
23 Gunda V, Souchek J, Abrego J, Shukla SK, Goode GD, Vernucci E, Dasgupta A, Chaika NV, King RJ, Li S, Wang S, Yu F, Bessho T, Lin C, Singh PK. MUC1-Mediated Metabolic Alterations Regulate Response to Radiotherapy in Pancreatic Cancer. Clin Cancer Res 2017;23:5881-91. [PMID: 28720669 DOI: 10.1158/1078-0432.CCR-17-1151] [Cited by in Crossref: 33] [Cited by in F6Publishing: 22] [Article Influence: 6.6] [Reference Citation Analysis]
24 Lin J, Xia L, Liang J, Han Y, Wang H, Oyang L, Tan S, Tian Y, Rao S, Chen X, Tang Y, Su M, Luo X, Wang Y, Wang H, Zhou Y, Liao Q. The roles of glucose metabolic reprogramming in chemo- and radio-resistance. J Exp Clin Cancer Res 2019;38:218. [PMID: 31122265 DOI: 10.1186/s13046-019-1214-z] [Cited by in Crossref: 49] [Cited by in F6Publishing: 47] [Article Influence: 16.3] [Reference Citation Analysis]
25 Murthy D, Vernucci E, Goode G, Abrego J, Singh PK. Evaluating the Metabolic Impact of Hypoxia on Pancreatic Cancer Cells. Methods Mol Biol 2018;1742:81-93. [PMID: 29330792 DOI: 10.1007/978-1-4939-7665-2_8] [Reference Citation Analysis]
26 Mehla K, Singh PK. Metabolic Regulation of Macrophage Polarization in Cancer. Trends Cancer. 2019;5:822-834. [PMID: 31813459 DOI: 10.1016/j.trecan.2019.10.007] [Cited by in Crossref: 54] [Cited by in F6Publishing: 61] [Article Influence: 18.0] [Reference Citation Analysis]
27 Sikdar N, Saha G, Dutta A, Ghosh S, Shrikhande SV, Banerjee S. Genetic Alterations of Periampullary and Pancreatic Ductal Adenocarcinoma: An Overview. Curr Genomics 2018;19:444-63. [PMID: 30258276 DOI: 10.2174/1389202919666180221160753] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
28 Ahlsson F, Åkerud H, Schijven D, Olivier J, Sundström-Poromaa I. Gene Expression in Placentas From Nondiabetic Women Giving Birth to Large for Gestational Age Infants. Reprod Sci 2015;22:1281-8. [PMID: 25824011 DOI: 10.1177/1933719115578928] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
29 Marimuthu S, Rauth S, Ganguly K, Zhang C, Lakshmanan I, Batra SK, Ponnusamy MP. Mucins reprogram stemness, metabolism and promote chemoresistance during cancer progression. Cancer Metastasis Rev 2021;40:575-88. [PMID: 33813658 DOI: 10.1007/s10555-021-09959-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
30 Pang Z, Dong X, Deng H, Wang C, Liao X, Liao C, Liao Y, Tian W, Cheng J, Chen G, Yi H, Huang L. MUC1 triggers lineage plasticity of Her2 positive mammary tumors. Oncogene. [DOI: 10.1038/s41388-022-02320-y] [Reference Citation Analysis]
31 Huang HL, Wu HY, Chu PC, Lai IL, Huang PH, Kulp SK, Pan SL, Teng CM, Chen CS. Role of integrin-linked kinase in regulating the protein stability of the MUC1-C oncoprotein in pancreatic cancer cells. Oncogenesis 2017;6:e359. [PMID: 28692035 DOI: 10.1038/oncsis.2017.61] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
32 Vlahopoulos SA. Aberrant control of NF-κB in cancer permits transcriptional and phenotypic plasticity, to curtail dependence on host tissue: molecular mode. Cancer Biol Med 2017;14:254-70. [PMID: 28884042 DOI: 10.20892/j.issn.2095-3941.2017.0029] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 5.2] [Reference Citation Analysis]
33 Lincet H, Icard P. How do glycolytic enzymes favour cancer cell proliferation by nonmetabolic functions? Oncogene 2015;34:3751-9. [PMID: 25263450 DOI: 10.1038/onc.2014.320] [Cited by in Crossref: 100] [Cited by in F6Publishing: 104] [Article Influence: 12.5] [Reference Citation Analysis]
34 Kobayashi H, Sugimoto H, Onishi S, Nakano K. Novel biomarker candidates for the diagnosis of ovarian clear cell carcinoma. Oncol Lett 2015;10:612-8. [PMID: 26622542 DOI: 10.3892/ol.2015.3367] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
35 Brockhausen I, Elimova E, Woodward AM, Argüeso P. Glycosylation pathways of human corneal and conjunctival epithelial cell mucins. Carbohydr Res 2018;470:50-6. [PMID: 30392563 DOI: 10.1016/j.carres.2018.10.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
36 Syrkina MS, Maslakova AA, Potashnikova DM, Veiko VP, Vassetzky YS, Rubtsov MA. Dual Role of the Extracellular Domain of Human Mucin MUC1 in Metastasis. J Cell Biochem 2017;118:4002-11. [PMID: 28407289 DOI: 10.1002/jcb.26056] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
37 Pastor-Soler NM, Sutton TA, Mang HE, Kinlough CL, Gendler SJ, Madsen CS, Bastacky SI, Ho J, Al-Bataineh MM, Hallows KR, Singh S, Monga SP, Kobayashi H, Haase VH, Hughey RP. Muc1 is protective during kidney ischemia-reperfusion injury. Am J Physiol Renal Physiol 2015;308:F1452-62. [PMID: 25925251 DOI: 10.1152/ajprenal.00066.2015] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 3.6] [Reference Citation Analysis]
38 Agrawal B. New therapeutic targets for cancer: the interplay between immune and metabolic checkpoints and gut microbiota. Clin Transl Med 2019;8:23. [PMID: 31468283 DOI: 10.1186/s40169-019-0241-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
39 Wang S, You L, Dai M, Zhao Y. Mucins in pancreatic cancer: A well-established but promising family for diagnosis, prognosis and therapy. J Cell Mol Med. 2020;24:10279-10289. [PMID: 32745356 DOI: 10.1111/jcmm.15684] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
40 Goode G, Gunda V, Chaika NV, Purohit V, Yu F, Singh PK. MUC1 facilitates metabolomic reprogramming in triple-negative breast cancer. PLoS One 2017;12:e0176820. [PMID: 28464016 DOI: 10.1371/journal.pone.0176820] [Cited by in Crossref: 11] [Cited by in F6Publishing: 17] [Article Influence: 2.2] [Reference Citation Analysis]
41 Sheng YH, Ng GZ, Summers KM, Every AL, Price G, Hasnain SZ, Sutton P, McGuckin MA. Influence of the MUC1 Cell Surface Mucin on Gastric Mucosal Gene Expression Profiles in Response to Helicobacter pylori Infection in Mice. Front Cell Infect Microbiol 2020;10:343. [PMID: 32793510 DOI: 10.3389/fcimb.2020.00343] [Reference Citation Analysis]
42 Saeki N, Sakamoto H, Yoshida T. Mucin 1 gene (MUC1) and gastric-cancer susceptibility. Int J Mol Sci 2014;15:7958-73. [PMID: 24810688 DOI: 10.3390/ijms15057958] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
43 Azevedo R, Peixoto A, Gaiteiro C, Fernandes E, Neves M, Lima L, Santos LL, Ferreira JA. Over forty years of bladder cancer glycobiology: Where do glycans stand facing precision oncology? Oncotarget 2017;8:91734-64. [PMID: 29207682 DOI: 10.18632/oncotarget.19433] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 3.8] [Reference Citation Analysis]
44 Vernucci E, Abrego J, Gunda V, Shukla SK, Dasgupta A, Rai V, Chaika N, Buettner K, Illies A, Yu F, Lazenby AJ, Swanson BJ, Singh PK. Metabolic Alterations in Pancreatic Cancer Progression. Cancers (Basel) 2019;12:E2. [PMID: 31861288 DOI: 10.3390/cancers12010002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
45 Al-Bataineh MM, Sutton TA, Hughey RP. Novel roles for mucin 1 in the kidney. Curr Opin Nephrol Hypertens 2017;26:384-91. [PMID: 28622163 DOI: 10.1097/MNH.0000000000000350] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
46 Wu G, Kim D, Kim JN, Park S, Maharjan S, Koh H, Moon K, Lee Y, Kwon HJ. A Mucin1 C-terminal Subunit-directed Monoclonal Antibody Targets Overexpressed Mucin1 in Breast Cancer. Theranostics 2018;8:78-91. [PMID: 29290794 DOI: 10.7150/thno.21278] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
47 Chalick M, Jacobi O, Pichinuk E, Garbar C, Bensussan A, Meeker A, Ziv R, Zehavi T, Smorodinsky NI, Hilkens J, Hanisch FG, Rubinstein DB, Wreschner DH. MUC1-ARF-A Novel MUC1 Protein That Resides in the Nucleus and Is Expressed by Alternate Reading Frame Translation of MUC1 mRNA. PLoS One 2016;11:e0165031. [PMID: 27768738 DOI: 10.1371/journal.pone.0165031] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]